How reliable is perioperative anticoagulant management? Determining guideline compliance and practice variation by a retrospective patient record review
Authors:
Open Access
Abstract
Objectives Surgery in patients on anticoagulants requires careful monitoring and risk assessment to prevent harm. Required interruptions of anticoagulants and deciding whether to use bridging anticoagulation add further complexity. This process, known as perioperative anticoagulant management (PAM), is optimised by using guidelines. Optimal PAM prevents thromboembolic and bleeding complications. The purpose of this study was to assess the reliability of PAM practice in Dutch hospitals. Additionally, the variations between hospitals and different bridging dosages were studied. Design A multicentre retrospective patient record review. Setting and participants Records from 268 patients using vitamin-K antagonist (VKA) anticoagulants who underwent surgery in a representative random sample of 13 Dutch hospitals were reviewed, 259 were analysed. Primary and secondary outcome measures Our primary outcome measure was the reliability of PAM expressed as the percentage of patients receiving guideline compliant care. Seven PAM steps were included. Secondary outcome measures included different bridging dosages used and an analysis of practice variation on the hospital level. Results Preoperative compliance was lowest for timely VKA interruptions: 58.8% (95% CI 50.0% to 67.7%) and highest for timely preoperative assessments: 81% (95% CI 75.0% to 86.5%). Postoperative compliance was lowest for timely VKA restarts: 39.9% (95% CI 33.1% to 46.7%) and highest for the decision to apply bridging: 68.5% (95% CI 62.3% to 74.8%). Variation in compliance between hospitals was present for the timely preoperative assessment (range 41%–100%), international normalised ratio testing (range 21%–94%) and postoperative bridging (range 20%–88%). Subtherapeutic bridging was used in 50.5% of patients and increased with patients’ weight. Conclusions Unsatisfying compliance for most PAM steps, reflect suboptimal reliability of PAM. Furthermore, the hospital performance varied. This increases the risk for adverse events, warranting quality improvement. The development of process measures can help but will be complicated by the availability of a strong supporting evidence base and integrated care delivery regarding PAM.Keywords
Funding Information
- Ministerie van Volksgezondheid, Welzijn en Sport
This publication has 37 references indexed in Scilit:
- A National Model for Developing, Implementing, and Evaluating Evidence‐based Guidelines for Prehospital CareAcademic Emergency Medicine, 2012
- Perioperative Management of Antithrombotic TherapyChest, 2012
- Evidence-Based Management of Anticoagulant TherapyChest, 2012
- Nature, Occurrence and Consequences of Medication-Related Adverse Events During HospitalizationDrug Safety, 2010
- Incidence of Adverse Drug Events and Medication Errors in Japan: the JADE StudyJournal of General Internal Medicine, 2010
- Patients requiring interruption of long‐term oral anticoagulant therapy: the use of fixed sub‐therapeutic doses of low‐molecular‐weight heparinJournal of Thrombosis and Haemostasis, 2009
- Standardized Low–Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or SurgeryCirculation, 2009
- Lost in knowledge translation: Time for a map?Journal of Continuing Education in the Health Professions, 2006
- Single-Arm Study of Bridging Therapy With Low-Molecular-Weight Heparin for Patients at Risk of Arterial Embolism Who Require Temporary Interruption of WarfarinCirculation, 2004
- Prosthetic Heart ValvesNew England Journal of Medicine, 1996